Phase IV Clinical Trial of an Influenza Split Vaccine Anflu
Clinical trial NCT00556062 · COMPLETED
Trial details
- NCT number
- NCT00556062
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.